Properly structured and implemented, diagnostic patent pools could integrate complementary technologies, reduce transaction costs and spur innovation.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Intellectual Property Rights and Access in Crisis
IIC - International Review of Intellectual Property and Competition Law Open Access 09 March 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Merz, J.F. Clin. Chem. 45, 324–330 (1999).
Barton, J.H. Acad. Med. 77, 1339–1347 (2002).
Eisenberg, R.S. Acad. Med. 77, 1381–1387 (2002).
Andrews, L.B. Nat. Rev. Genet. 3, 803–808 (2002).
107th Congress, Gene Patenting. H.R. 3966 and H.R. 3967.
Antitrust Guidelines for the Licensing of Intellectual Property issued by the US Department of Justice and the Federal Trade Commission, § 5.5 (1995).
Grody, W.W. et al. Genet. Med. 3, 149–154 (2001).
Goldstein, J.A., Ebersole, T.J., Guthrie, M.C., Hirschfeld, A.A. & van den Broek, B.J. Drug Discov. World Spring, 87–91 (2005).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ebersole, T., Guthrie, M. & Goldstein, J. Patent pools and standard setting in diagnostic genetics. Nat Biotechnol 23, 937–938 (2005). https://doi.org/10.1038/nbt0805-937
Issue Date:
DOI: https://doi.org/10.1038/nbt0805-937
This article is cited by
-
Intellectual Property Rights and Access in Crisis
IIC - International Review of Intellectual Property and Competition Law (2021)
-
Models for facilitating access to patents on genetic inventions
Nature Reviews Genetics (2006)